[1] Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats[J]. Lab Invest, 1996, 74(1):86-107.
[2] Roy S, Khanna S, Kuhn DE, et al. Transcriptome analysis of the ischemia-reperfused remodeling myocardium:temporal changes in inflammation and extracellular matrix[J]. Physiol Genom, 2006, 25(3):364-374.
[3] van den Akker F, Deddens JC, Doevendans PA, et al. Cardiac stem cell therapy to modulate inflammation upon myocardial infarction[J]. Biochem Biophys Acta, 2013, 1830(2):2449-2458.
[4] Arslan F, de Kleijn DP, Pasterkamp G. Innate immune signaling in cardiac ischemia[J]. Nat Rev Cardiol, 2011,8(5):292-300.
[5] Chen C, Feng Y, Zou L, et al. Role of extracellular RNA and TLR3-Trif signaling in myocardial ischemia-reperfusion injury[J]. J Am Heart Assoc, 2014, 3(1):e000683.
[6] Liehn EA, Merx MW, Postea O, et al. Ccr1 deficiency reduces inflammatory remodelling and preserves left ventricular function after myocardial infarction[J]. J Cell Mol Med, 2008, 12(2):496-506.
[7] Chello M, Anselmi A, Spadaccio C, et al. Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery[J]. Ann Thorac Surg, 2007, 83(4):1374-1380.
[8] Buyukkaya E, Poyraz F, Karakas MF, et al. Usefulness of monocyte chemoattractant protein-1 to predict no-reflow and three-year mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Am J Cardiol, 2013, 112(2):187-193.
[9] Dong F, Harvey J, Finan A, et al. Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction[J]. Circulation, 2012, 126(3):314-324.
[10] Miller EJ, Li J, Leng L, et al. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart[J]. Nature, 2008, 451(7178):578-582.
[11] Gao XM, Liu Y, White D, et al. Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury:a predominant role of anti-inflammation[J]. J Mol Cell Cardiol, 2011, 50(6):991-999.
[12] Bradley JR. TNF-mediated inflammatory disease[J]. J Pathol, 2008, 214(2):149-160.
[13] Peter ME, Krammer PH. The CD95(APO-1/Fas) DISC and beyond[J]. Cell Death Differ, 2003, 10(1):26-35.
[14] Zhang R, Xu Y, Ekman N, et al. Etk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway[J]. J Biol Chem, 2003,278(51):51267-51276.
[15] Miyazaki Y, Kaikita K, Endo M, et al. C/EBP homologous protein deficiency attenuates myocardial reperfusion injury by inhibiting myocardial apoptosis and inflammation[J]. Arterioscler Thromb Vasc Biol, 2011, 31(5):1124-1132.
[16] Oyadomari S, Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress[J]. Cell Death Differ, 2004, 11(4):381-389.
[17] Li Y, Schwabe RF, DeVries-Seimon T, et al. Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-a and interleukin-6:model of NF-kappaB-and map kinase-dependent inflammation in advanced atherosclerosis[J]. J Biol Chem, 2005, 280(23):21763-21772.
[18] Krishnamurthy P, Lambers E, Verma S, et al. Myocardial knockdown of mRNA-stabilizing protein HuR attenuates post-MI inflammatory response and left ventricular dysfunction in IL-10-null mice[J]. FASEB J, 2010, 24(7):2484-2494.
[19] Krishnamurthy P, Rajasingh J, Lambers E, et al. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR[J]. Circ Res, 2009, 104(2):e9-18.
[20] Zhao M, He X, Bi XY, et al. Vagal stimulation triggers peripheral vascular protection through the cholinergic anti-inflammatory pathway in a rat model of myocardial ischemia/reperfusion[J]. Basic Res Cardiol, 2013, 108(3):345.
[21] Kakinuma Y, Ando M, Kuwabara M, et al. Acetylcholine from vagal stimulation protects cardiomyocytes against ischemia and hypoxia involving additive non-hypoxic induction of HIF-1alpha[J]. FEBS Lett, 2005, 579(10):2111-2118.
[22] Ottani A, Giuliani D, Galantucci M, et al. Melanocortins counteract inflammatory and apoptotic responses to prolonged myocardial ischemia/reperfusion through a vagus nerve-mediated mechanism[J]. Eur J Pharmacol, 2010, 637(1-3):124-130.
[23] Takai S, Jin D, Miyazaki M. Multiple mechanisms for the action of chymase inhibitors[J]. J Pharmacol Sci, 2012, 118(3):311-316.
[24] Oyamada S, Bianchi C, Takai S, et al. Chymase inhibition reduces infarction and matrix metalloproteinase-9 activation and attenuates inflammation and fibrosis after acute myocardial ischemia/reperfusion[J]. J Pharmacol Exp Ther, 2011, 339(1):143-151.
[25] Chao J, Chao L. Kallikrein-kinin in stroke, cardiovascular and renal disease[J]. Exp Physiol, 2005, 90(3):291-298.
[26] Chao J, Yin H, Gao L, et al. Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formation[J]. Hypertension, 2008, 52(4):715-720.
[27] Stadnicki A. Intestinal tissue kallikrein-kinin system in inflammatory bowel disease[J]. Inflamm Bowel Dis, 2011, 17(2):645-654.
[28] Yao YY, Yin H, Shen B, et al. Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction[J]. Regul Pept, 2007, 140(1-2):12-20.
[29] Rodrigo R, Prieto JC, Castillo R. Cardioprotection against ischaemia/reperfusion by vitamins C and E plus n-3 fatty acids:molecular mechanisms and potential clinical applications[J]. Clin Sci, 2013, 124(1):1-15.
[30] Oropeza M, Petersen B, Carnwath JW, et al. Transgenic expression of the human A20 gene in cloned pigs provides protection against apoptotic and inflammatory stimuli[J]. Xenotransplantation, 2009, 16(6):522-534.
[31] Hunt DL, Campbell PH, Zambon AC, et al. Early postmyocardial infarction survival in Murphy Roths Large mice is mediated by attenuated apoptosis and inflammation but depends on genetic background[J]. Exp Physiol, 2012, 97(1):102-114.
[32] Meybohm P, Gruenewald M, Albrecht M, et al. Hypothermia and postconditioning after cardiopulmonary resuscitation reduce cardiac dysfunction by modulating inflammation, apoptosis and remodeling[J]. PLoS ONE, 2009, 4(10):e7588.
[33] Diepenhorst GM, Ciurana CL, Diaz Padilla N, et al. IgM antibodies against apoptotic cells and phosphorylcholine in patients with acute myocardial infarction in relation to infarct size and inflammatory response[J]. Adv Clin Exp Med, 2012, 21(4):455-467.
[34] Vincent A, Lattuca B, Merlet N, et al. New insights in research about acute ischemic myocardial injury and inflammation[J]. Antiinfl Antialler Agents Med Chem, 2013, 12(1):47-54.